Author

F. Gartner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Butsyk· 1 shared A. De Sousa Linhares· 1 shared A. Ferreira· 1 shared A. Loboda· 1 shared A. Lopes· 1 shared A. Lundquist· 1 shared A. M. Carmo· 1 shared A. Novoa· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Butsyk

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Shifting KRAS hotspot mutations inhibition paradigm in colorectal cancer

A. R. Bras, A. Lopes, N. Mendes, P. J. Costa, A. Ferreira, S. Granja, A. P. Silva, F. Tortosa, F. Baltazar, F. Gartner, M. J. Sousa, A. Valente, A. Preto

This study identifies a ruthenium compound, PMC79, that selectively inhibits KRAS mutations in colorectal cancer and enhances chemotherapy efficacy.

bioRxiv · Aug 9, 2023 · PreprintPharmacology & Toxicology

Helicobacter pylori attachment-blocking antibodies protect against duodenal ulcer disease

T. Boren, J. A. Bugaytsova, K. Moonens, A. Piddubnyi, A. Schmidt, J. O. Edlund, G. Lisiutin, K. Brannstrom, Y. A. Chernov, K. Thorell, I. Tkachenko, O. Sharova, I. Vikhrova, A. Butsyk, P. Shubin, , P. Aro

The paper shows that antibodies blocking H. pylori attachment reduce chronic inflammation and duodenal ulcer risk by mimicking BabA's binding to ABO glycans.

bioRxiv · May 24, 2023 · PreprintImmunology

The dual character of the inhibitory functions of CD6

R. F. Santos, A. De Sousa Linhares, M. S. Cardoso, A. Novoa, H. Luche, F. Gartner, B. Malissen, P. Steinberger, S. Davis, M. Mallo, L. Oliveira, A. M. Carmo

This study investigates CD6's dual inhibitory and costimulatory functions, showing it suppresses T cell responsiveness via its cytoplasmic domain and modulates autoimmunity through extracellular interactions.

bioRxiv · Apr 29, 2022 · PreprintImmunology